CDK4 and prostate cancer: In comparison with quiescent status of prostate cancer cells, we noticed an accumulation in cyclin D1, CDK4, cyclin E and CDK2 together with the expected reappearance of phosphorylated pRb when the quiescent cancer cells were induced to re-enter the cell cycle.